REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Crh Zagiel Med Sp. Z O.O. sp. j. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Pharmacies and Drug Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | Offices of Physicians | Offices of Dentists | Offices of All Other Miscellaneous Health Practitioners | All Other Miscellaneous Ambulatory Health Care Services
Full name: Crh Zagiel Med Sp. Z O.O. sp. j. Profile Updated: August 10, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Żagiel Med is a rehabilitation company based in Poland. The company focuses on engaging healthy body parts and utilizing remaining reserves in the body to motivate patients to further work.

Headquarters
Ul. Kazimierza Przerwy-Tetmajera 21
Lublin; Lubelskie; Postal Code: 20-362

Contact Details: Purchase the Crh Zagiel Med Sp. Z O.O. sp. j. report to view the information.

Website: http://www.zagielmed.pl

Basic Information
Total Employees:
Purchase the Crh Zagiel Med Sp. Z O.O. sp. j. report to view the information.
Outstanding Shares:
Purchase the Crh Zagiel Med Sp. Z O.O. sp. j. report to view the information.
Incorporation Date:
September 18, 2009
Key Executives
Company Performance
Financial values in the chart are available after Crh Zagiel Med Sp. Z O.O. sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
24.12%▲
Total operating revenue
18.93%▲
Operating profit (EBIT)
-550.93%▼
EBITDA
N/A
Net Profit (Loss) for the Period
-438.09%▼
Total assets
-28.13%▼
Total equity
-36.27%▼
Operating Profit Margin (ROS)
-4.43%▼
Net Profit Margin
-7.13%▼
Return on Equity (ROE)
12.03%▲
Debt to Equity Ratio
38.72%▲
Quick Ratio
-1.04%▼
Cash Ratio
-0.64%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo